Black Diamond Therapeutics (BDTX) Net Equity Issued and Repurchased (2019 - 2026)
Black Diamond Therapeutics' Net Equity Issued and Repurchased came in at -$32,000 for Q2 2025, compared with $21.01 million a year earlier.
Powered by 
Analysis
Black Diamond Therapeutics (BDTX) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2025, Black Diamond Therapeutics reported Net Equity Issued and Repurchased of -$500,000; for FY2024, it was $24.49 million, down 65.9% from FY2023.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -28.3% (FY2019 to FY2024).
- Going back by year, Net Equity Issued and Repurchased was $71.85 million in FY2023, $177,000 in FY2022 (-75.7%), $729,000 in FY2021 (-99.7%) and $213.84 million in FY2020 (+65.1%).
- The five-year range for quarterly Net Equity Issued and Repurchased is -$500,000 (Q3 2024) to $71.8 million (Q3 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,160.65 Bn | 1,129.23 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 633.19 Bn | 551.72 Bn | 17.26 Bn | 138.00 Mn |
| 3 | AbbVie | 501.90 Bn | 475.01 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 377.07 Bn | 331.45 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 302.35 Bn | 266.34 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 240.68 Bn | 196.07 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.20 Bn | 167.40 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn | - |
| 10 | Black Diamond Therapeutics | 118.75 Mn | -374.17 Mn | - | 217,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 217,000.00 |
| Mar 31, 2026 | -185,000.00 |
| Dec 31, 2025 | -146,000.00 |
| Sep 30, 2025 | 84,000.00 |
| Jun 30, 2025 | -116,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | -500,000.00 |
| Jun 30, 2024 | 20.86 Mn |
| Mar 31, 2024 | 4.13 Mn |
| Dec 31, 2023 | -46,000.00 |
| Sep 30, 2023 | 71.93 Mn |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | -28,000.00 |
| Sep 30, 2022 | 52,000.00 |
| Mar 31, 2022 | 153,000.00 |
| Sep 30, 2021 | 64,000.00 |
| Jun 30, 2021 | 184,000.00 |
| Mar 31, 2021 | 481,000.00 |
| Dec 31, 2020 | 830,000.00 |
API Access
Black Diamond Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BDTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "BDTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BDTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();